Hesperidin as a Multi‐Target Phytochemical: Therapeutic Applications, Medicinal Chemistry Insights, and Advances in Synthetic Analogs
Food Frontiers · 2026-11 · 7 (6)
DOI: 10.1002/fft2.70390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food Frontiers, online erschienen am 15.11.2026. Verfasst von Mohammadsaeed Kordi und 5 weiteren Autor:innen. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hesperidin (Hsd) is a citrus flavanone 7‐O‐rutinoside with extensive experimental evidence of antioxidant, anti‐inflammatory, cardiometabolic, neuroprotective, tissue‐protective, and anticancer activities. However, interpretation of these effects is complicated by poor aqueous solubility, limited intestinal absorption, microbiota‐dependent conversion to its aglycone hesperetin (Hst), and extensive phase II metabolism. This structured narrative review integrates current evidence on the natural occurrence, pharmacokinetics, biological activities, medicinal chemistry, structure–activity relationship, and drug‐delivery strategies of Hsd, Hst, and their derivatives. Quantitative source data confirm citrus peel as the principal natural reservoir but demonstrate substantial species‐, cultivar‐, and processing‐dependent variability. Across therapeutic domains, Hsd/Hst influence interconnected redox, inflammatory, vascular, neurotrophic, and cell‐survival pathways; nevertheless, most mechanistic and efficacy evidence remains preclinical. Selected cardiometabolic and inflammatory endpoints have relatively strong human evidence, while neuroprotective and anticancer applications are not sufficiently clinically validated. Studies in medicinal chemistry underscore the importance of glycosylation, phenolic substitution, C‐6/C‐7 modification, carbonyl editing and scaffold remodeling as key determinants of solubility, cellular accessibility and endpoint‐specific activity. Advanced formulations may improve dissolution and exposure, but formulation‐driven efficacy should not be equated with increased intrinsic potency. In conclusion, successful development of Hsd‐based therapeutics requires convergence of molecular activity, exposure, metabolite biology, formulation feasibility, and method validation.
Zitieren
APA
Kordi, M., Asadi, A., Aliabadi, A., Bayanati, M., Omidifard, N., & Rabbani, S. M. (2026). Hesperidin as a Multi‐Target Phytochemical: Therapeutic Applications, Medicinal Chemistry Insights, and Advances in Synthetic Analogs. Food Frontiers, 7(6). https://doi.org/10.1002/fft2.70390
Vancouver
Kordi M, Asadi A, Aliabadi A, Bayanati M, Omidifard N, Rabbani SM. Hesperidin as a Multi‐Target Phytochemical: Therapeutic Applications, Medicinal Chemistry Insights, and Advances in Synthetic Analogs. Food Frontiers. 2026;7(6). doi:10.1002/fft2.70390
BibTeX
@article{Kordi2026,
author = {Kordi, Mohammadsaeed and Asadi, Asma and Aliabadi, Ali and Bayanati, Maryam and Omidifard, Nima and Rabbani, Seyyed Mohammad},
title = {Hesperidin as a Multi‐Target Phytochemical: Therapeutic Applications, Medicinal Chemistry Insights, and Advances in Synthetic Analogs},
journal = {Food Frontiers},
year = {2026},
volume = {7},
number = {6},
doi = {10.1002/fft2.70390}
}
EUVIMED